Tokyo Medical University
Fractional flow reserve may be used to determine revascularization
Published in Telemedicine Business Week, September 21st, 2005
According to investigators in Japan, "The objective of [our] study was to examine the usefulness of fractional flow reserve (FFR) in determining the indication of target lesion revascularization (TLR) at follow-up angiography after percutaneous coronary intervention (PCI)."
Y. Kobori and colleagues of Tokyo Medical University explained, "One hundred forty-seven patients with 155 lesions that had intermediate restenosis took part in this study. FFR was measured in all patients for the evaluation of stenosis...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
More Articles from Telemedicine Business Week
- Finance
CCA has entered into an agreement for a private placement of its common stock - Image Technology Laboratories
Medical imaging company improves cash position and liquidity - Oridion Systems
Medical device company revenues increased 24% in second quarter of 2005 - VisEn Medical
Molecular imaging products company raises $4 million venture capital financing - Xenogen Corp.
Biophotonic imaging company completes $15 million private equity financing - Apical Ballooning Syndrome
Clinical features elucidated via myocardial contrast echocardiography - More from this issue of Telemedicine Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
